Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ENTA

Enanta Pharmaceuticals Inc

May 08 • 04:00PM ET

15.34

+0.25 1.66 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AVIR ABUS INO BNTC OCGN

| Held by: VTI IWM VXF IWN IBB SCHA VTWO DWAS VFMO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.20	Insider Own	5.09%	Shs Outstand	29.02M	Perf Week	6.90%
Market Cap	445.16M	Forward P/E	-	EPS next Y	-1.89	Insider Trans	-0.86%	Shs Float	27.54M	Perf Month	9.96%
Enterprise Value	452.49M	PEG	-	EPS next Q	-0.49	Inst Own	91.31%	Short Float	7.63%	Perf Quarter	13.55%
Income	-71.54M	P/S	6.65	EPS this Y	39.10%	Inst Trans	15.70%	Short Ratio	12.80	Perf Half Y	40.48%
Sales	66.98M	P/B	3.52	EPS next Y	18.99%	ROA	-21.10%	Short Interest	2.10M	Perf YTD	-2.73%
Book/sh	4.36	P/C	2.40	EPS next 5Y	20.58%	ROE	-60.01%	52W High	17.15 -10.55%	Perf Year	188.35%
Cash/sh	6.40	P/FCF	-	EPS past 3/5Y	13.40% -16.17%	ROIC	-25.14%	52W Low	4.96 209.25%	Perf 3Y	-55.32%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.82% -11.81%	Gross Margin	92.64%	Volatility	6.43% 5.35%	Perf 5Y	-68.37%
Dividend TTM	-	EV/Sales	6.76	EPS Y/Y TTM	35.29%	Oper. Margin	-109.08%	ATR (14)	0.77	Perf 10Y	-38.57%
Dividend Ex-Date	-	Quick Ratio	4.44	Sales Y/Y TTM	0.58%	Profit Margin	-106.80%	RSI (14)	67.74	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	4.44	EPS Q/Q	60.43%	SMA20	8.49%	Beta	1.01	Target Price	19.88
Payout	-	Debt/Eq	1.53	Sales Q/Q	9.76%	SMA50	12.38%	Rel Volume	1.17	Prev Close	15.09
Employees	120	LT Debt/Eq	1.25	Earnings	Feb 09 AMC	SMA200	27.77%	Avg Volume	164.20K	Price	15.34
IPO	Mar 21, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	45.29% 17.04%	Trades		Volume	191,717	Change	1.66%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)